Association of ApaI Rs7975232 and BsmI Rs1544410 in Clinical Outcomes of COVID-19 Patients According to Different SARS-CoV-2 Variants

Overview

Journal Sci Rep

Specialty Science

Date 2023 Mar 3

PMID 36869206

Authors

Ayad Naji Radha Al-Gharrawi

Enayat Anvari

Abolfazl Fateh

Affiliations

Soon will be listed here.

Abstract

A growing body of research has shown how important vitamin D is in the prognosis of coronavirus disease 19 (COVID-19). The vitamin D receptor is necessary for vitamin D to perform its effects, and its polymorphisms can help in this regard. Therefore, we aimed to evaluate whether the association of ApaI rs7975232 and BsmI rs1544410 polymorphisms in different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants were influential in the outcomes of COVID-19. The polymerase chain reaction-restriction fragment length polymorphism method was utilized to determine the different genotypes of ApaI rs7975232 and BsmI rs1544410 in 1734 and 1450 patients who had recovered and deceased, respectively. Our finding revealed that the ApaI rs7975232 AA genotype in the Delta and Omicron BA.5 and the CA genotype in the Delta and Alpha variants were associated with higher mortality rate. Also, the BsmI rs1544410 GG genotype in the Delta and Omicron BA.5 and the GA genotype in the Delta and Alpha variants were related to a higher mortality rate. The A-G haplotype was linked with COVID-19 mortality in both the Alpha and Delta variants. The A-A haplotype for the Omicron BA.5 variants was statistically significant. In conclusion, our research revealed a connection between SARS-CoV-2 variants and the impacts of ApaI rs7975232 and BsmI rs1544410 polymorphisms. However, more research is still needed to substantiate our findings.

Citing Articles

Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy.

Gomaa A, Abdel-Wadood Y, Thabet R, Gomaa G Inflammopharmacology. 2023; 32(1):249-271.

PMID: 37957515 PMC: 10907442. DOI: 10.1007/s10787-023-01383-x.

The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants.

Sheikhian F, Sadeghi Mofrad S, Tarashi S, Ghazanfari Jajin M, Sakhaee F, Ahmadi I Hum Genomics. 2023; 17(1):54.

PMID: 37328914 PMC: 10273585. DOI: 10.1186/s40246-023-00501-8.

References

Zeidan N, Abd El Lateef H, Selim D, Razek S, Abd-Elrehim G, Nashat M . Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19. Pediatr Res. 2022; 93(5):1383-1390. PMC: 9461391. DOI: 10.1038/s41390-022-02275-6. View

Apaydin T, Polat H, Yazan C, Ilgin C, Elbasan O, Dashdamirova S . Effects of vitamin D receptor gene polymorphisms on the prognosis of COVID-19. Clin Endocrinol (Oxf). 2021; 96(6):819-830. DOI: 10.1111/cen.14664. View

Qayyum S, Mohammad T, Slominski R, Hassan M, Tuckey R, Raman C . Vitamin D and lumisterol novel metabolites can inhibit SARS-CoV-2 replication machinery enzymes. Am J Physiol Endocrinol Metab. 2021; 321(2):E246-E251. PMC: 8328521. DOI: 10.1152/ajpendo.00174.2021. View

Hasan H, AbuOdeh R, Bin Wan Muda W, Jan Bin Jan Mohamed H, Samsudin A . Association of Vitamin D receptor gene polymorphisms with metabolic syndrome and its components among adult Arabs from the United Arab Emirates. Diabetes Metab Syndr. 2017; 11 Suppl 2:S531-S537. DOI: 10.1016/j.dsx.2017.03.047. View

Gois P, Ferreira D, Olenski S, Seguro A . Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?. Nutrients. 2017; 9(7). PMC: 5537771. DOI: 10.3390/nu9070651. View

Garcia-Lledo A, Gomez-Pavon J, Gonzalez Del Castillo J, Hernandez-Sampelayo T, Martin-Delgado M, Martin Sanchez F . Pharmacological treatment of COVID-19: an opinion paper. Rev Esp Quimioter. 2021; 35(2):115-130. PMC: 8972693. DOI: 10.37201/req/158.2021. View

Albu-Mohammed W, Anvari E, Fateh A . Evaluating the Role of rs739837 and rs731236 Polymorphisms in Vitamin D Receptor with SARS-CoV-2 Variants Mortality Rate. Genes (Basel). 2022; 13(12). PMC: 9777972. DOI: 10.3390/genes13122346. View

Song Y, Qayyum S, Greer R, Slominski R, Raman C, Slominski A . Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study. J Biomol Struct Dyn. 2021; 40(22):11594-11610. PMC: 8858339. DOI: 10.1080/07391102.2021.1964601. View

Roth D, Jones A, Prosser C, Robinson J, Vohra S . Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J Infect Dis. 2008; 197(5):676-80. DOI: 10.1086/527488. View

10.

Kresfelder T, Janssen R, Bont L, Pretorius M, Venter M . Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J Med Virol. 2011; 83(10):1834-40. DOI: 10.1002/jmv.22179. View

11.

Abdollahzadeh R, Shushizadeh M, Barazandehrokh M, Choopani S, Azarnezhad A, Paknahad S . Association of Vitamin D receptor gene polymorphisms and clinical/severe outcomes of COVID-19 patients. Infect Genet Evol. 2021; 96:105098. PMC: 8487094. DOI: 10.1016/j.meegid.2021.105098. View

12.

Cimmino G, Conte S, Morello M, Pellegrino G, Marra L, Morello A . Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection?. J Cardiovasc Dev Dis. 2022; 9(1). PMC: 8781542. DOI: 10.3390/jcdd9010027. View

13.

Malek Mahdavi A . A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment for COVID-19. Rev Med Virol. 2020; 30(5):e2119. PMC: 7362103. DOI: 10.1002/rmv.2119. View

14.

He Q, Huang Y, Zhang L, Yan Y, Liu J, Song X . Association between vitamin D receptor polymorphisms and hepatitis B virus infection susceptibility: A meta-analysis study. Gene. 2017; 645:105-112. DOI: 10.1016/j.gene.2017.12.027. View

15.

Uitterlinden A, Fang Y, van Meurs J, Pols H, van Leeuwen J . Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2):143-56. DOI: 10.1016/j.gene.2004.05.014. View

16.

Greiller C, Martineau A . Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015; 7(6):4240-70. PMC: 4488782. DOI: 10.3390/nu7064240. View

17.

Sanchez de la Torre M, Torres C, Nieto G, Vergara S, Carrero A, Macias J . Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J Infect Dis. 2008; 197(3):405-10. DOI: 10.1086/525043. View

18.

Varikasuvu S, Thangappazham B, Vykunta A, Duggina P, Manne M, Raj H . COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert Rev Anti Infect Ther. 2022; 20(6):907-913. PMC: 8862170. DOI: 10.1080/14787210.2022.2035217. View

19.

Qayyum S, Slominski R, Raman C, Slominski A . Novel CYP11A1-Derived Vitamin D and Lumisterol Biometabolites for the Management of COVID-19. Nutrients. 2022; 14(22). PMC: 9698837. DOI: 10.3390/nu14224779. View

20.

van Etten E, Verlinden L, Giulietti A, Ramos-Lopez E, Branisteanu D, Ferreira G . The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007; 37(2):395-405. DOI: 10.1002/eji.200636043. View